Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer | Patent Number 10456420

US 10456420 B2
Application Number15529848
Publication NumberUS 20180193383 A1
Pendency3 years, 7 months, 8 days
Filled DateMar 25, 2016
Priority DateMar 27, 2015
Publication DateJul 12, 2018
Expiration DateMar 26, 2035
Inventor/ApplicantsTien Lee
Hans G. Klingemann
Barry J. Simon
Laurent Boissel
ExaminesDUFFY, BRADLEY
Art Unit1643
Technology Center1600
Assignments
Infinity Sa Llc
Current
Nantkwest
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.